Godavari Biorefineries Limited (GODAVARIB) — Announcement

StockFin.ai Try Free →

📢 Key Event
Company granted Japanese patent for cancer treatment compound

💡 Investor Takeaway
The patent strengthens Godavari's oncology pipeline and long-term shareholder value.

Godavari Biorefineries announced that Japan's patent office granted a patent for its cancer-treating compound, covering a novel class of molecules effective against breast and prostate cancer. The patent, numbered 7869786, was registered on May 26, 2026, and includes a grant certificate attached to the filing. This intellectual property milestone strengthens the company's oncology pipeline and long-term value potential for shareholders.

📄 View Original Announcement (PDF)

📊 Stock Analysis — GODAVARIB ✨ Ask AI About This